ARCHIVES

Also FDA clarifies data requirements for phase I IND applications.

This article is from The Cancer Letter archive.

Vol. 31 No. 17 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

Other Concepts Approves By DCE Board Last Week

June 20, 1986

ICCCR to Focus Its Efforts on Prevention Research

February 22, 1991

Pat Barr, Early NBCC Activist, Dead.

June 27, 2003

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013

Conversation with The Cancer Letter: Is Republican Control Better Than Two-Party Stalemate?

December 19, 2014